Correlation Between Adial Pharmaceuticals and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals WT and Eyenovia, you can compare the effects of market volatilities on Adial Pharmaceuticals and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Eyenovia.
Diversification Opportunities for Adial Pharmaceuticals and Eyenovia
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Adial and Eyenovia is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals WT and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals WT are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Eyenovia go up and down completely randomly.
Pair Corralation between Adial Pharmaceuticals and Eyenovia
Assuming the 90 days horizon Adial Pharmaceuticals WT is expected to generate 6.02 times more return on investment than Eyenovia. However, Adial Pharmaceuticals is 6.02 times more volatile than Eyenovia. It trades about 0.17 of its potential returns per unit of risk. Eyenovia is currently generating about -0.07 per unit of risk. If you would invest 1.75 in Adial Pharmaceuticals WT on August 29, 2024 and sell it today you would lose (1.14) from holding Adial Pharmaceuticals WT or give up 65.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 8.91% |
| Values | Daily Returns |
Adial Pharmaceuticals WT vs. Eyenovia
Performance |
| Timeline |
| Adial Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Eyenovia |
Adial Pharmaceuticals and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adial Pharmaceuticals and Eyenovia
The main advantage of trading using opposite Adial Pharmaceuticals and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.The idea behind Adial Pharmaceuticals WT and Eyenovia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Eyenovia vs. Capricor Therapeutics | Eyenovia vs. Soleno Therapeutics | Eyenovia vs. Bio Path Holdings | Eyenovia vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |